arrow
Y

Yosuke Nakagawa

Tokai University
H指数:17
被引数:1,059

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review

双特异性抗体在终末期肾病并接受血液透析的多发性骨髓瘤患者中的有效性与安全性:elranatamab病例报告及文献综述

2025-10-290
OA
Resistance mechanisms and efficacy of first-line (1L) alectinib in patients (pts) with ALK-rearranged non-small cell lung cancer (ALK plus NSCLC): Second interim analysis of ALCURE

ALK易位非小细胞肺癌(ALK plus NSCLC)患者中,一线(1L)阿来替尼的耐药机制与疗效:ALCURE研究的第二次中期分析

2024-12-010
PRE
Inhibition of the ATR kinase enhances 5-FU sensitivity independently of nonhomologous end-joining and homologous recombination repair pathways

抑制ATR激酶可增强5-FU敏感性,而不受非同源末端连接和同源重组修复途径的影响

2020-09-018
OAAI
Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [18F]-L-FBPA positron emission tomography in boron neutron capture therapy
2016-11-0850
OAAI